Hepatitis A susceptibility parallels high COVID-19 mortality

Hepatitis A susceptibility parallels high COVID-19 mortality

Background/aim:COVID-19 has become the biggest health problem of this century. It has been hypothesized that immunity against hepatitis A virus (HAV) may provide protection from COVID- 19. Materials and methods: As of 10June 2020, the infection had spread to 213 countries, with 7.3 million people infected and 413,733 dead. This data was combined with the World Health Organization susceptibility classification on the worldwide prevalence of HAV, and the relationship between HAV susceptibility and COVID-19 mortality were analyzed. Results: When the data from 213 countries were analyzed, it was found that there was a significant increasing trend in COVID-19 mortality rates by HAV susceptibility (P

___

  • 1. Sarialioglu F, Belen Apak FB, Haberal M. Can hepatitis A vaccine provide protection against COVID-19? Experimental and Clinical Transplantation 2020; 18 (2): 141‐143. doi: 10.6002/ect.2020.0109
  • 2. Jacobsen KH. The global prevalence of hepatitis A virus infection and susceptibility: a systematic review. Report number: WHO/IVB/10.01. Geneva, Switzerland: World Health Organization; 2009.
  • 3. Sakurai A, Sasaki T, Kato S, Hayashi M, Tsuzuki SI et al. Natural history of asymptomatic SARS-CoV-2 infection. The New England Journal of Medicine 2020; 383: 885-886. doi: 10.1056/NEJMc2013020
  • 4. Nelson NP. Travel related infectious diseases- hepatitis A. In: Brunette GW, Nemhauser JB (editors). Centers for Disease Control and Prevention. CDC Yellow Book 2020: Health Information for International Travel. New York, NY, USA: Oxford University Press; 2017.
Turkish Journal of Medical Sciences-Cover
  • ISSN: 1300-0144
  • Yayın Aralığı: 6
  • Yayıncı: TÜBİTAK
Sayıdaki Diğer Makaleler

Hydroxychloroquine plus azithromycin and early hospital admission are beneficial in COVID-19 patients: Turkish experience with real-life data

Binnaz Zeynep YILDIRIM, Mehmet Akif ÖZGÜL, Efsun Gonca UĞUR CHOUSEIN, Demet TURAN, Elif TANRIVERDİ, Erdoğan ÇETİNKAYA, Halit ÇINARKA, Mustafa ÇÖRTÜK

Clinical and oncological outcomes of the low ligation of the inferior mesenteric artery with robotic surgery in patients with rectal cancer following neoadjuvant chemoradiotherapy

Orhan ARAS, İsmail GÖMCELİ

Does fludrocortisone treatment cause hypomagnesemia in children with primary adrenal insufficiency?

Gönül ÇATLI, Ayhan ABACI, Ahmet ANIK, Tolga ÜNÜVAR, İbrahim Mert ERBAŞ, Bayram ÖZHAN, Selda Ayça ALTINCIK

Hepatitis A susceptibility parallels high COVID-19 mortality

Fatma Burcu BELEN, Kadir Mutlu HAYRAN, Faik SARIALİOĞLU

Comparison of the clinical and sonographic effects of ultrasound therapy, extracorporeal shock wave therapy, and Kinesio taping in lateral epicondylitis

Bülent ÖZKURT, Tarık ÖZMEN, Salih Süha KOPARAL, Özlem KARATAŞ, Filiz ESER, Ümit GAFUROĞLU

Comprehensive assessment of levodopa-carbidopa intestinal gel for Turkish advanced Parkinson’s disease patients

Yeşim SÜCÜLLÜ KARADAĞ, Tankut KÖSEOĞLU, Emin ALTIPARMAK, Ömer ÖZTÜRK, Tuğçe SALTOĞLU, Fadime ERDOĞAN KÜÇÜKDAĞLI

Imaging modalities used in diagnosis and follow-up of patients with Takayasu’s arteritis

Levent KILIÇ, Abdulsamet ERDEN, Ayşe Bahar KELEŞOĞLU DİNÇER, Umut KALYONCU, Sedat KİRAZ, Ömer KARADAĞ, Tuncay HAZIROLAN

Lateral frontal galeal-cutaneous flap for reconstruction after orbital exenteration for advanced periorbital skin cancer

Predrag KOVACEVIC, Jasmina DJORDJEVIC-JOCIC, Milan RADOJKOVIC

Family-centeredness of services for young children with Down syndrome: an observational study from Turkey

Funda AKPINAR, Emine Bahar BİNGÖLER PEKCİCİ, Ezgi ÖZALP AKIN, Gamze HAYRAN, Cansu KELEŞ, Betül YAĞBASAN, İlgi ÖZTÜRK ERTEM, Nazmiye KURŞUN

Efficacy, retention, and safety of tofacitinib in real-life: Hur-bio monocentric experience

Levent KILIÇ, Emre BİLGİN, Ali AKDOĞAN, Umut KALYONCU, Sedat KİRAZ, Ömer KARADAĞ, Ali İhsan ERTENLİ, Gözde Kübra YARDIMCI, Emine DURAN, , Ertuğrul Çağrı BÖLEK, Furkan CEYLAN, Bayram FARİSOĞULLARI, Şule Apraş BİLGEN